A Comparative Analysis of Weizmannia coagulans Genomes Unravels the Genetic Potential for Biotechnological Applications
- PMID: 35328559
- PMCID: PMC8954581
- DOI: 10.3390/ijms23063135
A Comparative Analysis of Weizmannia coagulans Genomes Unravels the Genetic Potential for Biotechnological Applications
Abstract
The production of biochemicals requires the use of microbial strains with efficient substrate conversion and excellent environmental robustness, such as Weizmannia coagulans species. So far, the genomes of 47 strains have been sequenced. Herein, we report a comparative genomic analysis of nine strains on the full repertoire of Carbohydrate-Active enZymes (CAZymes), secretion systems, and resistance mechanisms to environmental challenges. Moreover, Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) immune system along with CRISPR-associated (Cas) genes, was also analyzed. Overall, this study expands our understanding of the strain's genomic diversity of W. coagulans to fully exploit its potential in biotechnological applications.
Keywords: B. coagulans; CAZymes; CRISPR-Cas systems; bacteriocins.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Gupta R.S., Patel S., Saini N., Chen S. Robust demarcation of 17 distinct bacillus species clades, proposed as novel bacillaceae genera, by phylogenomics and comparative genomic analyses: Description of Robertmurraya kyonggiensis sp. nov. and proposal for an emended genus bacillus limiting it o. Int. J. Syst. Evol. Microbiol. 2020;70:5753–5798. doi: 10.1099/ijsem.0.004475. - DOI - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
